Small Pharma Stock Book Value Per Share
| DMTTFDelisted Stock | USD 0.05 0.0009 1.80% |
Small Pharma fundamentals help investors to digest information that contributes to Small Pharma's financial success or failures. It also enables traders to predict the movement of Small OTC Stock. The fundamental analysis module provides a way to measure Small Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Small Pharma otc stock.
Small |
Small Pharma OTC Stock Book Value Per Share Analysis
Small Pharma's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Small Pharma Book Value Per Share | 0.06 X |
Most of Small Pharma's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Small Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
CompetitionIn accordance with the recently published financial statements, the book value per share of Small Pharma is about 0.059 times. This is 103.47% lower than that of the Healthcare sector and 100.02% lower than that of the Biotechnology industry. The book value per share for all United States stocks is 100.0% higher than that of the company.
Small Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Small Pharma's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Small Pharma could also be used in its relative valuation, which is a method of valuing Small Pharma by comparing valuation metrics of similar companies.Small Pharma is currently under evaluation in book value per share category among its peers.
Small Fundamentals
| Return On Equity | -0.78 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 24.67 M | |||
| Shares Outstanding | 321.56 M | |||
| Shares Owned By Insiders | 31.08 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Price To Book | 1.15 X | |||
| Price To Sales | 69,846 X | |||
| Gross Profit | 45 K | |||
| EBITDA | (22.47 M) | |||
| Net Income | (22.27 M) | |||
| Cash And Equivalents | 27.15 M | |||
| Cash Per Share | 0.08 X | |||
| Current Ratio | 6.62 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (16.23 M) | |||
| Earnings Per Share | (0.06) X | |||
| Number Of Employees | 10 | |||
| Market Capitalization | 27.33 M | |||
| Total Asset | 45.57 M | |||
| Net Asset | 45.57 M |
About Small Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Small Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Small Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Small Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Small OTC Stock
If you are still planning to invest in Small Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Small Pharma's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |